Recombinant Human Mitochondrial proton/calcium exchanger protein (LETM1)

Shipped with Ice Packs
In Stock

Description

Recombinant LETM1 exhibits two primary activities validated through in vitro reconstitution assays:

Ion Transport

  • Ca²⁺/H⁺ Antiport: Mediates proton-dependent calcium efflux from mitochondria with a stoichiometry of 1 Ca²⁺:2 H⁺ . Activity is pH-dependent, increasing by 300% when the proton gradient rises from ΔpH 0.5 to 1.5 .

  • K⁺/H⁺ Exchange: Electroneutral exchange observed in yeast complementation studies, though this remains debated in human systems .

Mechanistic Insights

  • Glu221 Residue: Mutation of this residue (e.g., Glu221→Gln) abolishes Ca²⁺/H⁺ antiport activity, confirming its role in ion coordination .

  • Hexameric Structure: Cryo-EM reveals a hexameric assembly with a central pore, suggesting a channel-like mechanism for ion transport .

Disease Relevance

ConditionRole of LETM1 DysfunctionReferences
Wolf-Hirschhorn syndromeHaploinsufficiency linked to mitochondrial fragmentation
Parkinson’s diseaseImpaired PINK1-mediated phosphorylation disrupts Ca²⁺ homeostasis
CancerOverexpression correlates with metabolic reprogramming

Experimental Applications

Recombinant LETM1 is pivotal for:

  • Drug Screening: Used in liposome-based assays to identify modulators of mitochondrial Ca²⁺ flux .

  • Cristae Biogenesis Studies: Reconstituted proteoliposomes model cristae formation mechanisms .

  • Respiratory Chain Analysis: CRISPR-edited cell lines with LETM1 knockdown show 40–60% reductions in Complex III/IV activity .

Challenges and Future Directions

  • Functional Controversy: Discrepancies persist between Ca²⁺/H⁺ and K⁺/H⁺ antiport activities across models .

  • Therapeutic Targeting: Nanodisc-embedded recombinant LETM1 enables high-throughput screening for neurodegenerative disease therapies .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate specific requests. Please indicate your desired format in the order notes, and we will fulfill your needs.
Lead Time
Delivery time may vary depending on the purchase method and location. Please consult your local distributors for precise delivery estimates.
Note: All protein shipments are standardly packaged with blue ice packs. If dry ice packaging is required, please inform us in advance, as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. For optimal use, store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents are at the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. To ensure long-term stability, we suggest adding 5-50% glycerol (final concentration) and aliquoting for storage at -20°C/-80°C. Our standard final concentration of glycerol is 50%, which can be used as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer composition, temperature, and protein stability.
Generally, the shelf life for liquid form is 6 months at -20°C/-80°C, while lyophilized form has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. For multiple uses, aliquoting is necessary. To maintain protein integrity, avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
We will prioritize your specified tag type if you have provided it. Otherwise, we will select the most suitable tag during production.
Synonyms
LETM1; Mitochondrial proton/calcium exchanger protein; Leucine zipper-EF-hand-containing transmembrane protein 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
116-739
Protein Length
Full Length of Mature Protein
Species
Homo sapiens (Human)
Target Names
LETM1
Target Protein Sequence
DDSVVEKSLKSLKDKNKKLEEGGPVYSPPAEVVVKKSLGQRVLDELKHYYHGFRLLWIDTKIAARMLWRILNGHSLTRRERRQFLRICADLFRLVPFLVFVVVPFMEFLLPVAVKLFPNMLPSTFETQSLKEERLKKELRVKLELAKFLQDTIEEMALKNKAAKGSATKDFSVFFQKIRETGERPSNEEIMRFSKLFEDELTLDNLTRPQLVALCKLLELQSIGTNNFLRFQLTMRLRSIKADDKLIAEEGVDSLNVKELQAACRARGMRALGVTEDRLRGQLKQWLDLHLHQEIPTSLLILSRAMYLPDTLSPADQLKSTLQTLPEIVAKEAQVKVAEVEGEQVDNKAKLEATLQEEAAIQQEHREKELQKRSEVAKDFEPERVVAAPQRPGTEPQPEMPDTVLQSETLKDTAPVLEGLKEEEITKEEIDILSDACSKLQEQKKSLTKEKEELELLKEDVQDYSEDLQEIKKELSKTGEEKYVEESKASKRLTKRVQQMIGQIDGLISQLEMDQQAGKLAPANGMPTGENVISVAELINAMKQVKHIPESKLTSLAAALDENKDGKVNIDDLVKVIELVDKEDVHISTSQVAEIVATLEKEEKVEEKEKAKEKAEKEVAEVKS
Uniprot No.

Target Background

Function
This protein functions as a mitochondrial proton/calcium antiporter. It mediates proton-dependent calcium efflux from the mitochondrion, playing a crucial role in maintaining mitochondrial tubular networks and assembling respiratory chain supercomplexes. LETM1 is essential for preserving the tubular shape and cristae organization of mitochondria. Unlike SLC8B1/NCLX, it is not the primary factor responsible for mitochondrial calcium extrusion.
Gene References Into Functions
  1. Research has shown that LETM1 knockdown exhibits tumor-suppressive effects, potentially by regulating the downstream Wnt/beta-catenin signaling pathway. PMID: 29048663
  2. Data suggest a positive correlation between LETM1 up-regulation, YAP1 nuclear localization, and high PDGFB expression. PMID: 27556512
  3. LETM1 plays a significant role in the progression of breast cancer. PMID: 26722481
  4. Overexpression of LETM1 protein is linked to Triple negative breast cancer progression and may serve as a potential biomarker for poor prognosis. PMID: 25617527
  5. LETM1 is implicated in the progression of head and neck squamous cell carcinoma. PMID: 24689060
  6. Letm1 expression is reduced in patients with intractable TLE and a rat model of epilepsy. Down-regulation of Letm1 leads to increased mitochondrial swelling and decreased MT-CYB expression, which is associated with seizure susceptibility. PMID: 23645710
  7. Restoration of LETM1 or overexpression of antioxidants rescued mitochondrial Ca(2+) transport and bioenergetics. PMID: 25077561
  8. These findings highlight novel cellular phenotypes in Wolf-Hirschhorn syndrome attributable to a 50% reduction in LETM1 expression. PMID: 24626991
  9. Haploinsufficiency of WHSC1 and/or LETM1 contributes to Wolf-Hirschhorn Syndrome, but loss of distinct and/or additional genes in 4p16.3 is required for the expression of the core Wolf-Hirschhorn Syndrome phenotype. PMID: 23963300
  10. NCLX, but not LETM1, mediates Ca(2+) extrusion from mitochondria. By controlling the duration of matrix Ca(2+) elevations, NCLX contributes to the regulation of NAD(P)H production and the conversion of Ca(2+) signals into redox changes. PMID: 24898248
  11. Functional properties of Letm1 described in this study closely resemble those of the H(+)-dependent Ca(2+) transport mechanism observed in intact mitochondria. PMID: 24344246
  12. Data indicate that loss of Letm1 contributes to the pathology of Wolf-Hirschhorn syndrome and may contribute to seizure phenotypes by reducing glucose oxidation and other specific metabolic alterations. PMID: 23716663
  13. This work summarizes current understanding regarding the functions of LETM1 and its role in pathophysiology, with emphasis on its potential as a candidate for regulating mitochondrial Ca2+ homeostasis. PMID: 22641639
  14. Letm1 and UCP2/3 independently contribute to two distinct, mitochondrial Ca(2+) uptake pathways in intact endothelial cells. PMID: 21613221
  15. Researchers identified a novel submicroscopic duplication involving dosage sensitive genes TACC3, FGFR3, and LETM1. PMID: 21815251
  16. LETM1 suppressed lung cancer cell growth in vitro and in vivo. PMID: 20824095
  17. LETM1 is evolutionarily conserved throughout the eukaryotic kingdom and localized to the mitochondria. PMID: 14706454
  18. This study presents cellular and biochemical analysis of Letm1. PMID: 17606466
  19. Findings indicate that human LETM1 is located in the inner membrane, exposed to the matrix, and oligomerized in higher molecular weight complexes of unknown composition; down-regulation of LETM1 caused 'necrosis-like' death, without caspase activation. PMID: 17925330
  20. The study explored the LETM1-mediated regulation of mitochondrial volume and its interaction with the mitochondrial AAA-ATPase BCS1L, which is associated with three different human disorders. PMID: 18628306
  21. LETM1 protein is a novel binding partner for Carboxyl-terminal modulator protein, potentially playing a crucial role in mitochondrial fragmentation via optic atrophy type 1-cleavage. PMID: 19168126
  22. Data suggest that LETM1 serves as an anchor protein for complex formation with the mitochondrial ribosome and regulates mitochondrial biogenesis. Increased LETM1 expression in human cancer suggests that dysregulation of LETM1 is implicated in tumorigenesis. PMID: 19318571
  23. Letm1 was found to specifically mediate coupled Ca2+/H+ exchange; RNAi knockdown, overexpression, and liposome reconstitution of the purified Letm1 protein demonstrate that Letm1 is a mitochondrial Ca2+/H+ antiporter. PMID: 19797662

Show More

Hide All

Database Links

HGNC: 6556

OMIM: 604407

KEGG: hsa:3954

STRING: 9606.ENSP00000305653

UniGene: Hs.120165

Protein Families
LETM1 family
Subcellular Location
Mitochondrion inner membrane; Single-pass membrane protein.

Q&A

What is the domain architecture of LETM1 protein?

Human LETM1 is an 83.4 kDa protein that is processed to a 70 kDa mature form upon cleavage of its signal peptide (~13.4 kDa). Its structure includes:

  • N-terminal domain (residues 115-208) oriented in the mitochondrial intermembrane space

  • A putative coiled-coil domain (residues 115-136) preceded by a signal peptide (residues 1-114)

  • Single transmembrane domain (residues 209-229) spanning the inner mitochondrial membrane

  • Large C-terminal domain (residues 230-739) localized within the mitochondrial matrix

  • A putative canonical EF-hand motif (residues 663-698)

  • Three predicted coiled-coil domains in the C-terminal region (CC2: 462-490; CC3: 537-627; CC4: 708-739)

A second non-canonical EF-hand motif has been suggested to exist (residues 569-597) within the C-terminal domain, embedded in the coiled-coil 3 region . This complex structure suggests multiple functional roles within mitochondria, particularly in ion transport activities.

What is the primary function of LETM1 in mitochondria?

LETM1 primarily functions as a Ca²⁺/H⁺ exchanger (CHE) in the inner mitochondrial membrane, although there remains some debate in the field. In vitro proteoliposome assays have demonstrated that LETM1:

  • Mediates rapid accumulation and extrusion of Ca²⁺ but not K⁺

  • Drives Ca²⁺ exchange for H⁺ and vice versa, with transport observed concomitant with pH changes

  • Shows strong affinity for Ca²⁺ with transport interference by similar divalent cations, especially manganese (Mn²⁺)

What cell-based experimental models are effective for studying LETM1 function?

Several experimental approaches have proven effective for investigating LETM1 function:

RNA Interference (RNAi) Models:

  • Transient knockdown using siRNAs in cell lines (e.g., Flp-In-293 cells) allows investigation of short-term responses to protein loss while minimizing long-term developmental or compensatory mechanisms

  • RNAi in Trypanosoma brucei has been used to demonstrate LETM1's role in maintaining mitochondrial potassium homeostasis

Measurement Parameters:

  • Ca²⁺ homeostasis: Fluorescent Ca²⁺ indicators to monitor mitochondrial calcium ([Ca²⁺]ᵐⁱᵗᵒ) levels

  • Membrane potential: Tetramethylrhodamine methyl ester (TMRM) accumulation to assess mitochondrial membrane potential

  • Cell viability and proliferation: ATP measurements and cell proliferation assays

When designing cell-based models, researchers should consider both short and long-term knockdown effects, as prolonged LETM1 deficiency progressively impacts cell proliferation rates despite initially maintaining normal ATP levels and membrane potential .

How can researchers effectively express and purify recombinant LETM1 for functional studies?

Producing functional recombinant LETM1 requires careful consideration of its membrane protein nature and structural elements:

Expression Systems:

  • Bacterial expression systems (e.g., E. coli) for specific domains, particularly the soluble C-terminal domain

  • Insect cell expression systems (e.g., Sf9 cells) for full-length protein with proper folding

  • Mammalian expression systems for studying post-translational modifications

Purification Strategy:

  • Add affinity tags (His-tag, GST) for initial purification

  • Include detergents suitable for membrane proteins (e.g., DDM, LMNG) throughout purification

  • Utilize size exclusion chromatography for final purification and oligomeric state assessment

Functional Reconstitution:

  • Reconstitution into proteoliposomes with defined lipid composition

  • Incorporate Ca²⁺ and H⁺ selective fluorophores or use radioactive Ca²⁺ and rubidium (Rb⁺) isotopes to measure transport activity

  • Create inside-out and right-side-out vesicles to study directionality of transport

Researchers should verify protein integrity through Western blotting and assess functionality through ion transport assays before proceeding to more complex experiments.

How does LETM1 regulate mitochondrial calcium levels under different physiological conditions?

LETM1 exhibits differential regulation of mitochondrial calcium depending on cytosolic calcium concentrations:

Low [Ca²⁺]ᶜʸᵗᵒ Conditions:

  • LETM1 is crucial for maintaining basal mitochondrial calcium levels

  • Knockdown results in dramatically reduced Ca²⁺ᵐⁱᵗᵒ uptake coupled with H⁺ᵐⁱᵗᵒ extrusion

  • Reduced steady-state [Ca²⁺]ᵐⁱᵗᵒ is observed in LETM1 knockdown cells in the presence of 10 mM Na⁺

High [Ca²⁺]ᶜʸᵗᵒ Conditions:

  • LETM1 knockdown cells still exhibit fast [Ca²⁺]ᵐⁱᵗᵒ rise to levels similar to controls

  • This suggests other calcium transport mechanisms (likely the mitochondrial calcium uniporter) predominate during high cytosolic calcium events

This dual behavior indicates LETM1 primarily functions in maintaining basal mitochondrial calcium homeostasis rather than handling large calcium transients. The activity is pH-dependent, suggesting tight coupling between proton and calcium movements across the inner mitochondrial membrane .

What experimental techniques are most effective for measuring LETM1-mediated ion exchange?

Researchers employ several complementary techniques to assess LETM1-mediated ion exchange:

In Vitro Proteoliposome Assays:

  • Reconstitution of purified LETM1 into liposomes

  • Use of Ca²⁺ and K⁺ selective fluorophores to monitor ion movements

  • Application of radioactive Ca²⁺ and rubidium (Rb⁺) isotopes to quantify transport

  • Creation of inward or outward ion gradients to demonstrate bidirectional exchange

Cellular Assays:

  • Genetically encoded or chemical Ca²⁺ indicators targeted to mitochondria

  • pH-sensitive fluorescent probes to monitor matrix pH changes

  • Simultaneous measurement of Ca²⁺ and H⁺ movements to establish stoichiometry

  • Patch-clamp electrophysiology of mitoplasts to measure currents

Ion Selectivity Experiments:

  • Testing transport of different divalent cations (Mn²⁺, Sr²⁺)

  • Using lanthanides and other inhibitors to block specific transport mechanisms

  • Measuring interference patterns between different ions to establish selectivity profiles

These techniques should be used in combination to provide comprehensive evidence of LETM1's transport properties and distinguish its activity from other mitochondrial transporters.

How does LETM1 impact mitochondrial energetics and cellular metabolism?

LETM1 influences mitochondrial energetics and cellular metabolism through several mechanisms:

Effects on Mitochondrial Function:

  • LETM1 deficiency affects mitochondrial calcium homeostasis, which is critical for proper TCA cycle enzyme function

  • Knockdown studies show minimal changes in mitochondrial membrane potential and similar or slightly higher TMRM accumulation

  • Some mitochondria with increased volume can be identified in LETM1 knockdown cells, although they maintain normal TMRM accumulation

Metabolic Consequences:

  • LETM1 null mice show reduced glucose oxidation, particularly affecting brain function

  • Metabolic profiling of tissues from these models can be performed using targeted LC-MS methods in both positive and negative ionization modes

  • Water-soluble metabolites can be analyzed using specific chromatographic conditions:

    • Negative mode: Luna NH2 column with gradient elution of ammonium acetate/hydroxide

    • Positive mode: Atlantis HILIC column with acetonitrile/ammonium formate gradient

Cellular Energy Production:

  • While transient LETM1 knockdown does not dramatically reduce total cellular ATP levels in Flp-In-293 cells

  • Long-term knockdown progressively reduces cell proliferation rates, suggesting cumulative effects on energy metabolism

These findings highlight LETM1's role in maintaining metabolic homeostasis, particularly in tissues with high energy demands such as the brain.

What is the current debate regarding LETM1's function as Ca²⁺/H⁺ vs. K⁺/H⁺ exchanger?

The exact ion exchange activity of LETM1 remains controversial in the field:

Evidence for Ca²⁺/H⁺ Exchange:

  • Proteoliposome assays show LETM1 reconstituted vesicles efficiently transport Ca²⁺ but not K⁺/Rb⁺

  • Ca²⁺ transport is observed concomitant with pH changes, indicating H⁺ counterexchange

  • LETM1 shows strong affinity for Ca²⁺ and similar divalent cations like Mn²⁺

  • The prevailing consensus is that LETM1's primary function is to mediate CHE activity across the inner mitochondrial membrane

Evidence for K⁺/H⁺ Exchange:

  • Studies in trypanosomes suggest LETM1 is essential for mitochondrial potassium homeostasis

  • LETM1 RNAi silencing in Trypanosoma brucei triggers swelling mitochondria that can be ameliorated by chemical potassium/proton exchangers

  • Some researchers propose LETM1 may indirectly affect K⁺ transport by stabilizing or activating K⁺ transporters in the inner mitochondrial membrane

Possible Resolution:

  • LETM1 may perform both activities either directly or through indirect means

  • Experimental conditions, model systems, and compensatory mechanisms may influence observed activities

  • Structural studies focusing on ion binding sites could help resolve this debate

Researchers addressing this question should employ multiple experimental systems and consider both direct and indirect effects of LETM1 on ion homeostasis.

How can structural biology approaches advance our understanding of LETM1 function?

Structural biology represents a critical approach to resolve outstanding questions about LETM1:

Current Structural Knowledge Gaps:

  • High-resolution structural information on LETM1 is a major knowledge gap in the field

  • The mechanistic role of the canonical Ca²⁺ binding EF-hand in LETM1 function remains unclear

  • The existence and function of a potential second EF-hand motif needs verification

  • Structural mechanisms of LETM1 inhibition by ruthenium red (RR), Ru-360, and CPG-37157 are undefined

Priority Structural Targets:

  • The assembled and functional LETM1 oligomer

  • Ca²⁺-bound versus Ca²⁺-free states to understand conformational changes

  • Structural effects of disease-associated mutations

  • Interactions with inhibitors and regulatory molecules

Methodological Approaches:

  • X-ray crystallography of isolated domains

  • Cryo-electron microscopy for full-length protein in different functional states

  • NMR studies of smaller domains and peptides

  • Molecular dynamics simulations to model ion permeation and selectivity

  • Cross-linking mass spectrometry to identify interaction surfaces

Resolving LETM1's structure would significantly advance our understanding of its ion selectivity and transport mechanisms, potentially resolving the debate about its primary substrate and providing insights into therapeutic interventions for LETM1-related diseases .

What are the implications of LETM1 in pathological conditions?

LETM1 dysfunction is implicated in several pathological conditions:

Wolf-Hirschhorn Syndrome (WHS):

  • LETM1 haplodeficiency is a key feature of WHS

  • Leads to dysfunctional mitochondrial Ca²⁺ handling

  • May contribute to seizures and developmental problems characteristic of WHS

Cancer:

  • Numerous cancer cells show upregulation of LETM1 expression

  • LETM1 may influence metabolic reprogramming in cancer cells

  • Potential therapeutic target for certain cancer types

Neurodegenerative Diseases:

  • LETM1's crucial role in brain function suggests potential involvement in neurodegenerative processes

  • LETM1 null mice show reduced glucose oxidation particularly affecting brain function

  • Disruption of mitochondrial calcium homeostasis is implicated in various neurodegenerative diseases

Research Approaches:

  • Patient-derived cells to study LETM1 expression and function

  • CRISPR-engineered cell lines with specific LETM1 mutations

  • Tissue-specific conditional knockout animal models

  • Metabolomic profiling to identify downstream effects of LETM1 dysfunction

  • Drug screening for compounds that can modulate LETM1 activity

Understanding LETM1's role in these conditions could guide development of new therapeutic strategies, diagnostic tests, and research tools to detect and treat WHS and other calcium signaling-related pathologies .

How can quantitative analysis of LETM1 expression be optimized in research settings?

Accurate quantification of LETM1 expression is crucial for research validity:

RNA-Level Analysis:

  • Quantitative real-time PCR using primers homologous to LETM1 mRNA

  • Specific primers (e.g., CGGAATACCTGTCGTCCACT and AGACATTAAACGGCCCTTCC) can be used

  • Relative abundance measurements should be normalized to housekeeping genes (18S rRNA or β-tubulin)

  • Northern blot analysis using antisense probes generated from PCR products

Protein-Level Analysis:

  • Western blotting with validated antibodies against different LETM1 domains

  • Consideration of the 83.4 kDa precursor versus 70 kDa mature form after signal peptide cleavage

  • Subcellular fractionation to confirm mitochondrial localization

  • Immunofluorescence microscopy for spatial distribution analysis

Experimental Controls:

  • Include both positive controls (overexpression systems) and negative controls (knockdown/knockout)

  • Consider inducible systems to study temporal aspects of expression

  • Account for potential compensatory mechanisms in chronic knockdown models

These methodological considerations ensure reliable quantification of LETM1 expression, which is essential for understanding its role in both physiological and pathological contexts .

What experimental approaches can distinguish direct versus indirect effects of LETM1 on ion transport?

Distinguishing direct from indirect effects requires careful experimental design:

Reconstitution in Defined Systems:

  • Purified recombinant LETM1 reconstituted into liposomes with defined lipid composition

  • Absence of other proteins ensures direct measurement of LETM1 activity

  • Systematic variation of lipid composition to assess environmental effects

  • Use of mutants with altered predicted ion-binding sites to confirm specificity

Acute Inhibition Strategies:

  • Application of LETM1-specific inhibitors in real-time assays

  • Electrophysiological recordings to capture immediate transport events

  • Rapid genetic approaches like auxin-inducible degron systems for acute protein depletion

Rescue Experiments:

  • Complementation of LETM1 knockout with:

    • Wild-type LETM1

    • Transport-deficient LETM1 mutants

    • LETM1 from diverse species to identify conserved functions

  • Chemical rescue experiments using synthetic ion transporters (e.g., nigericin for K⁺/H⁺ exchange)

Combined Measurements:

  • Simultaneous monitoring of multiple ion species to establish stoichiometry and coupling

  • Correlation analyses between different parameters to establish causality

  • Time-resolved measurements to capture sequential events

These approaches collectively provide stronger evidence for direct versus indirect effects of LETM1 on ion transport, helping resolve the ongoing debate about its primary function .

What emerging technologies could advance LETM1 research?

Several cutting-edge technologies hold promise for advancing LETM1 research:

Cryo-Electron Microscopy:

  • High-resolution structural analysis of LETM1 in different functional states

  • Visualization of LETM1 complexes with potential interacting partners

  • Structural basis for ion selectivity and transport mechanisms

CRISPR-Cas9 Genome Editing:

  • Generation of precise mutations mimicking disease-associated variants

  • Domain-specific modifications to dissect functional regions

  • Cell-type specific conditional knockouts to study tissue-dependent effects

Advanced Imaging Techniques:

  • Super-resolution microscopy to study LETM1 distribution within mitochondrial subdomains

  • Real-time imaging of ion fluxes with genetically encoded sensors

  • Correlative light and electron microscopy to link function with ultrastructure

Single-Molecule Techniques:

  • Single-molecule FRET to detect conformational changes during transport cycles

  • Nanodiscs for stabilization and functional studies of purified LETM1

  • Single-channel recordings to characterize transport properties

Multi-omics Integration:

  • Combining proteomics, metabolomics, and transcriptomics to understand LETM1's broader impact

  • Systems biology approaches to model LETM1's role in mitochondrial and cellular homeostasis

  • Patient-specific iPSC models to study disease variants in relevant cell types

These technologies will help address outstanding questions about LETM1's structure, function, and physiological roles in health and disease .

How can researchers address the current experimental challenges in determining LETM1 electrogenicity?

Understanding LETM1's electrogenicity (whether its transport is electrogenic or electroneutral) represents a significant challenge:

Experimental Approaches:

  • Patch-Clamp Electrophysiology:

    • Preparation of mitoplasts (mitochondria with outer membrane removed)

    • Whole-mitoplast patch-clamp recordings to measure currents

    • Ion substitution experiments to determine charge carriers

    • Specific inhibition of other channels/transporters to isolate LETM1 activity

  • Membrane Potential Measurements:

    • Use of potential-sensitive dyes in reconstituted proteoliposomes

    • Simultaneous measurement of membrane potential and ion fluxes

    • Experiments with varying ion gradients to determine coupling ratios

  • Charge Compensation Analysis:

    • Design of experiments that can distinguish between:

      • 1:1 Ca²⁺/2H⁺ electroneutral exchange

      • 1:1 Ca²⁺/H⁺ electrogenic exchange

    • Use of ionophores to selectively dissipate specific ion gradients

  • Purified System Studies:

    • Reconstitution of purified LETM1 into planar lipid bilayers

    • Solid-supported membrane electrophysiology

    • Ion flux measurements under voltage clamp conditions

These approaches, especially when combined, can help resolve whether LETM1 transport is electrogenic or electroneutral, which is crucial for understanding its physiological role and contribution to the mitochondrial membrane potential .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.